Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | KMO | O15229 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL460613 | 0.81 | RECQL (0.46) | RECQLCYP1A2KMOSLC6A2ADRA2A | |
| SCHEMBL30854464 | 0.78 | RECQL (0.43) | RECQLCYP1A2KMOSLC6A2ADRA2A | |
| SCHEMBL1966858 | 0.78 | RECQL (0.43) | RECQLCYP1A2KMOSLC6A2ADRA2A | |
| SCHEMBL31661043 | 0.77 | RECQL (0.43) | RECQLCYP1A2KMOSLC6A2ADRA2A | |
| SCHEMBL3534557 | 0.77 | RECQL (0.43) | RECQLCYP1A2KMOSLC6A2ADRA2A | |
| SCHEMBL63075 | 0.76 | RECQL (0.42) | RECQLCYP1A2KMOSLC6A2ADRA2A | |
| SCHEMBL11012727 | 0.76 | RECQL (0.42) | RECQLCYP1A2KMOSLC6A2ADRA2A | |
| SCHEMBL261758 | 0.74 | RECQL (0.41) | RECQLCYP1A2KMOADRA2AADRA2B | |
| SCHEMBL6495972 | 0.74 | CYP1A2 (0.38) | RECQLCYP1A2KMOADRA2AADRA2B | |
| SCHEMBL23860138 | 0.73 | CYP1A2 (0.40) | RECQLCYP1A2KMOSLC6A2ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12022672-B2 | Electronic semiconducting device, method for preparing the electronic semiconducting device and compound | NOVALED GMBH (DE) | 2024-06-25 | — | — | US | disclosed |
| EP-3364475-B1 | ELECTRONIC SEMICONDUCTING DEVICE, METHOD FOR PREPARING THE ELECTRONIC SEMICONDUCTING DEVICE AND COMPOUND | NOVALED GMBH (DE) | 2024-05-29 | — | — | EP | disclosed |
| EP-3583636-B1 | ELECTRONIC SEMICONDUCTING DEVICE, METHOD FOR PREPARING THE ELECTRONIC SEMICONDUCTING DEVICE AND COMPOUND | NOVALED GMBH (DE) | 2023-05-24 | — | — | EP | disclosed |
| US-20220416188-A1 | Electronic Semiconducting Device, Method for Preparing the Electronic Semiconducting Device and Compound | NOVALED GMBH (DE) | 2022-12-29 | — | — | US | disclosed |
| US-11539014-B2 | Electronic semiconducting device, method for preparing the electronic semiconducting device and compound | NOVALED GMBH (DE) | 2022-12-27 | — | — | US | disclosed |
| US-20060247124-A1 | Polymerisation reaction and catalyst therefor | JOHNSON MATTHEY PLC (GB) | 2006-11-02 | — | — | US | disclosed |
| EP-1569996-A1 | POLYMERISATION REACTION AND CATALYST THEREFOR | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2005-09-07 | — | — | EP | disclosed |
| WO-2004052980-A1 | POLYMERISATION REACTION AND CATALYST THEREFOR | JOHNSON MATTHEY PLC (GB) | 2004-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12022672-B2 | Electronic semiconducting device, method for preparing the electronic semiconducting device and compound | BTD, SLC6A3, EPCAM | RECQL 3092/4885CYP1A2 3286/4885KMO 1612/4885 |
| US-11539014-B2 | Electronic semiconducting device, method for preparing the electronic semiconducting device and compound | BTD, SLC6A3, EPCAM | RECQL 3153/4885CYP1A2 3316/4885KMO 1519/4885 |
| US-20220416188-A1 | Electronic Semiconducting Device, Method for Preparing the Electronic Semiconducting Device and Compound | BTD, SLC6A3, EPCAM | RECQL 3092/4885CYP1A2 3286/4885KMO 1612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.